The Health Ministry of Japan has suspended the use of vaccines made by Pfizer Inc and Sanofi-Aventis SA after five children were found dead. There was no clear link between the use of vaccines and deaths but the company officials are investigating further.

Failing of the cancer drug worth $800 million triggered the fall of shares of Sanofi-Aventis, the French Drug company which is eyeing to buy Genzyme, the U. S. biotech.

Sanofi developed the Iniparib, or BSI-201 for treating advanced breast cancer, failed to control the progress of the cancer.

Sanofi-Aventis is reported to have undergone two new cancer research deals. One of the cancer research tie-ups with Avila Therapeutics will aim to develop covalent drugs.

Europe’s number three oil producer ,Total SA stated that its third-quarter profit saw a rise of thirty two per cent as the form produced more taking up new fields in Europe, America and Africa

As the bid of sixty nine dollars per share by Sanofi-Aventis SA was turned down by Genzyme calling it too low for negotiating, Sanofis has launched a hostile takeover offer for the US biotechnology company with the value of eighteen decimal five billion dollars.

An proposal worth 18.5 billion dollar has been revealed by Sanofi Aventis, which is a pharmaceutical company based in France for Genzyme which is a biotechnology enterprise based in United States which focuses on creating remedies and medication for uncommon ailments.

Sanofi-Aventis, Pharma Giant on Sunday openly offered confirmation for the foremost time that it had bid for Genzyme Corp., earlier, and made a move to nudge investors of Genzyme to accept a proposal that the administration of Cambridge, Massachusetts, the firm up to now had snubbed.

On Thursday, one of the biggest drug company, Sanofi-Aventis posted an 8.6% increase in fourth-quarter net revenue, elevated by its diabetes drug Lantus, achievement and an increase from sales of A H1N1 flu vaccines.

The Sanofi-Aventis BioTalent Challenge, held in Ottawa, has got its youngest winner yet, after Rui Song, a 14 year old girl from Saskatoon won the first prize, at the competition.

Rui Song has deciphered a method of finding, whether a dangerous fungus that destroys the Lentil crop is present in the crop or not.

Sanofi-Aventis, the major French drug manufacturer, on Wednesday announced that it would be investing funds worth 150 Million Euros ($201.4 Million) over the coming four years in order to build up its biotechnology manufacturing facilities across France.